The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – A systematic review, meta-analysis, and meta-regression
Open accessAbstract
Background and aims Diabetes Mellitus (DM) is chronic conditions with devastating multi-systemic complication and may be associated with severe form of Coronavirus Disease 2019 (COVID-19). We conducted a systematic review and meta-analysis in order to investigate the association between DM and poor outcome in patients with COVID-19 pneumonia. Methods Systematic literature search was performed from several electronic databases on subjects that assess DM and outcome in COVID-19 pneumonia. The outcome of interest was composite poor outcome, including mortality, severe COVID-19, acute respiratory distress syndrome (ARDS), need for intensive care unit (ICU) care, and disease progression. Results There were a total of 6452 patients from 30 studies. Meta-analysis showed that DM was associated with composite poor outcome (RR 2.38 [1.88, 3.03], p < 0.001; I2: 62%) and its subgroup which comprised of mortality (RR 2.12 [1.44, 3.11], p < 0.001; I2: 72%), severe COVID-19 (RR 2.45 [1.79, 3.35], p < 0.001; I2: 45%), ARDS (RR 4.64 [1.86, 11.58], p = 0.001; I2: 9%), and disease progression (RR 3.31 [1.08, 10.14], p = 0.04; I2: 0%). Meta-regression showed that the association with composite poor outcome was influenced by age (p = 0.003) and hypertension (p < 0.001). Subgroup analysis showed that the association was weaker in studies with median age ≥55 years-old (RR 1.92) compared to <55 years-old (RR 3.48), and in prevalence of hypertension ≥25% (RR 1.93) compared to <25% (RR 3.06). Subgroup analysis on median age <55 years-old and prevalence of hypertension <25% showed strong association (RR 3.33) Conclusion DM was associated with mortality, severe COVID-19, ARDS, and disease progression in patients with COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884 · cited 1×
“[3, 8, [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] 9, [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [10] [11] [12] [13] [14] [15] [16] There were a total of 6452 patients from 30 studies.”
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A. A., Ogurtsova, K., et al. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107843 · Cited by 10,792
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
Ruan, Q., Yang, K., Wang, W., Jiang, L., & Song, J. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05991-x · Cited by 4,898
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775
Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020) · Journal of Virology · doi:10.1128/jvi.00127-20 · Cited by 4,341 · cited 2×
“[37, 39, 40] This enzyme acts by counteracting the inflammatory actions of angiotensin II, lowering the concentration of pro-inflammatory cytokine interleukin (IL)-6, increasing the anti-inflammatory, and increasing the antioxidant action of angiotensin 1-7, escalating the levels of surfactant protein D and promoting…”
Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yang, Y.-B., Yan, Y.-Q., Akdis, C. A., & Gao, Y.-D. (2020) · Allergy · doi:10.1111/all.14238 · Cited by 4,004
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
Fang, L., Karakiulakis, G., & Roth, M. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30116-8 · Cited by 2,911
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Wada, T., Leong-Poi, H., et al. (2005) · Nature · doi:10.1038/nature03712 · Cited by 2,453
Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19)
Gomes, C. A. (2020) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 2,134
Liu, J., Li, S., Liu, J., Liang, B., Wang, X., Wang, H., Li, W., Tong, Q., Yi, J., Zhao, L., et al. (2020) · eBioMedicine · doi:10.1016/j.ebiom.2020.102763 · Cited by 1,702
Diabetes is a risk factor for the progression and prognosis of COVID‐19
Guo, W., Li, M., Dong, Y., Zhou, H., Zhang, Z., Tian, C., Qin, R., Wang, H., Shen, Y., Du, K., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3319 · Cited by 1,404
Immune dysfunction in patients with diabetes mellitus (DM)
Geerlings, S. (1999) · FEMS Immunology and Medical Microbiology · doi:10.1016/s0928-8244(99)00142-x · Cited by 1,272
Clinical Characteristics of Coronavirus Disease 2019 in China
Eastin, C., & Eastin, T. (2020) · The Journal of Emergency Medicine · doi:10.1016/j.jemermed.2020.04.004 · Cited by 1,234
Liu, W., Tao, Z.-W., Wang, L., Yuan, M.-L., Liu, K., Zhou, L., Wei, S., Deng, Y., Liu, J., Liu, H.-G., et al. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000775 · Cited by 1,104
Liu, J., Liu, Y., Xiang, P., Pu, L., Xiong, H., Li, C., Zhang, M., Tan, J., Xu, Y., Song, R., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02374-0 · Cited by 1,082
Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing
Wan, S., Xiang, Y., Fang, W., Zheng, Y., Li, B., Hu, Y., Lang, C., Huang, D., Sun, Q., Xiong, Y., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25783 · Cited by 982 · cited 2×
“Subgroup analysis showed that DM was associated with mortality (RR 2. 12”
Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3541136 · Cited by 898
Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China
Zhang, G., Hu, C., Luo, L., Fang, F., Chen, Y., Li, J., Peng, Z., & Pan, H. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104364 · Cited by 694
Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19
Qu, R., Ling, Y., Zhang, Y., Wei, L., Chen, X., Li, X., Liu, X., Liu, H., Guo, Z., Ren, H., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25767 · Cited by 580
COVID‐19 in a designated infectious diseases hospital outside Hubei Province, China
Cai, Q., Huang, D., Ou, P., Yu, H., Zhu, Z., Xia, Z., Su, Y., Ma, Z., Zhang, Y., Li, Z., et al. (2020) · Allergy · doi:10.1111/all.14309 · Cited by 502
Yuan, M., Yin, W., Tao, Z., Tan, W., & Hu, Y. (2020) · PLOS ONE · doi:10.1371/journal.pone.0230548 · Cited by 498
The Effect of Short-Term Hyperglycemia on the Innate Immune System
Jafar, N., Edriss, H., & Nugent, K. (2016) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2015.11.011 · Cited by 463
COVID-19, diabetes mellitus and ACE2: The conundrum
Pal, R., & Bhansali, A. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108132 · Cited by 349
Feng, Z., Yu, Q., Yao, S., Luo, L., Zhou, W., Mao, X., Li, J., Duan, J., Yan, Z., Yang, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18786-x · Cited by 318
Covid‐19 and diabetes mellitus: unveiling the interaction of two pandemics
Maddaloni, E., & Buzzetti, R. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3321 · Cited by 305
Tabata, S., Imai, K., Kawano, S., Ikeda, M., Kodama, T., Miyoshi, K., Obinata, H., Mimura, S., Kodera, T., Kitagaki, M., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30482-5 · Cited by 296
Eastin, C., & Eastin, T. (2020) · The Journal of Emergency Medicine · doi:10.1016/j.jemermed.2020.04.007 · Cited by 263
Clinical Features of Patients Infected with the 2019 Novel Coronavirus (COVID-19) in Shanghai, China
Cao, M., Zhang, D., Wang, Y., Lu, Y., Zhu, X., Li, Y., Xue, H., Lin, Y., Zhang, M., Sun, Y., et al. (2020) · medRxiv · doi:10.1101/2020.03.04.20030395 · Cited by 199
AlGhatrif, M., Cingolani, O., & Lakatta, E. G. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1329 · Cited by 184
Romaní-Pérez, M., Outeiriño-Iglesias, V., Moya, C. M., Santisteban, P., González-Matías, L. C., Vigo, E., & Mallo, F. (2015) · Endocrinology · doi:10.1210/en.2014-1685 · Cited by 178
Clinical features and progression of acute respiratory distress syndrome in coronavirus disease 2019
Liu, Y., Sun, W., Li, J., Chen, L., Wang, Y., Zhang, L., & Yu, L. (2020) · medRxiv · doi:10.1101/2020.02.17.20024166 · Cited by 172
Ma, R. C. W., & Holt, R. I. G. (2020) · Diabetic Medicine · doi:10.1111/dme.14300 · Cited by 162
Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients
Rossi, G. P., Sanga, V., & Barton, M. (2020) · eLife · doi:10.7554/elife.57278 · Cited by 147
Gupta, R., & Misra, A. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.03.012 · Cited by 146
Predictors of fatality including radiographic findings in adults with COVID-19
Li, K., Chen, D., Chen, S., Feng, Y., Chang, C., Wang, Z., Wang, N., & Zhen, G. (2020) · Respiratory Research · doi:10.1186/s12931-020-01411-2 · Cited by 146
Clinical characteristics of 51 patients discharged from hospital with COVID-19 in Chongqing,ChinaPreprint
Liu, L., Gao, J.-Y., Hu, W.-M., Zhang, X.-X., Guo, L., Liu, C.-Q., Tang, Y.-W., Lang, C., Mou, F., Yi, Z.-J., et al. (2020) · medRxiv · doi:10.1101/2020.02.20.20025536 · Cited by 103
Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China
Wang, Y., Zhou, Y., Yang, Z. L., Xia, D., Hu, Y., & Geng, S. (2020) · Respiration · doi:10.1159/000507940 · Cited by 58
Characteristics of patients with COVID-19 during epidemic ongoing outbreak in Wuhan, ChinaPreprint
Luo, X., Xia, H., Yang, W., Wang, B., Guo, T., Xiong, J., Jiang, Z., Liu, Y., Yan, X., Zhou, W., et al. (2020) · medRxiv · doi:10.1101/2020.03.19.20033175 · Cited by 54
Hickerson, B. T., Westover, J. B., Wang, Z., Lee, Y.-M., & Gowen, B. B. (2019) · Journal of Virology · doi:10.1128/jvi.01278-19 · Cited by 44
Chen, M., Fan, Y., Wu, X., Zhang, L., Guo, T., Deng, K., Cao, J., Luo, H., He, T., Gong, Y., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3546069 · Cited by 43
Clinical Characteristics of SARS-CoV-2 Infections Involving 325 Hospitalized Patients outside WuhanPreprint
Li, Q., Ling, Y., Zhang, J., Li, W., Zhang, X., Jin, Y., Li, L., Fu, Q., Huang, Y., Lu, H., et al. (2020) · doi:10.21203/rs.3.rs-18699/v1 · Cited by 19
Tabata, S., Imai, K., Kawano, S., Ikeda, M., Kodama, T., Miyoshi, K., Obinata, H., Mimura, S., Kodera, T., Kitagaki, M., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3551331 · Cited by 14
Cited by
Barron, E., Bakhai, C., Kar, P., Weaver, A., Bradley, D., Ismail, H., Knighton, P., Holman, N., Khunti, K., Sattar, N., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30272-2 · Cited by 945
Holman, N., Knighton, P., Kar, P., O'Keefe, J., Curley, M., Weaver, A., Barron, E., Bakhai, C., Khunti, K., Wareham, N. J., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30271-0 · Cited by 908
Beyerstedt, S., Casaro, E. B., & Rangel, É. B. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-04138-6 · Cited by 897
Cariou, B., Hadjadj, S., Wargny, M., Pichelin, M., Al-Salameh, A., Allix, I., Amadou, C., Arnault, G., Baudoux, F., Bauduceau, B., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05180-x · Cited by 813
Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis
Huang, I., & Pranata, R. (2020) · Journal of Intensive Care · doi:10.1186/s40560-020-00453-4 · Cited by 662
Self-citation
Metadata
- Authors
- Huang, I., Lim, M. A., & Pranata, R.
- Venue
- Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 14
- Issue
- 4
- Pages
- 395-403
- ISSN
- 1871-4021 (ISSN-L)
- OpenAlex
- W3016370968
- Cited by
- 933
- References
- 50
- FWCI
- 11.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.